Qinghai Spring Medicinal Resources Technology Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.07%

Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has an Asset Resilience Ratio of 0.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600381 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥749.52K

≈ $109.68K USD Cash + Short-term Investments

Total Assets

CN¥1.02 Billion

≈ $149.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Asset Resilience Ratio has changed over time. See 600381 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Qinghai Spring Medicinal Resources Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Qinghai Spring Medicinal Resources Techn market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥749.52K	0.07%
Total Liquid Assets	CN¥749.52K	0.07%

Asset Resilience Insights

Limited Liquidity: Qinghai Spring Medicinal Resources Technology Co Ltd maintains only 0.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qinghai Spring Medicinal Resources Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Qinghai Spring Medicinal Resources Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Qinghai Spring Medicinal Resources Technology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.07%	CN¥739.32K ≈ $108.19K	CN¥1.04 Billion ≈ $152.84 Million	+0.01pp
2024-12-31	0.06%	CN¥742.73K ≈ $108.68K	CN¥1.16 Billion ≈ $170.37 Million	+0.01pp
2023-12-31	0.05%	CN¥670.29K ≈ $98.08K	CN¥1.36 Billion ≈ $198.91 Million	+0.01pp
2022-12-31	0.04%	CN¥656.75K ≈ $96.10K	CN¥1.56 Billion ≈ $228.16 Million	-1.83pp
2021-12-31	1.87%	CN¥34.65 Million ≈ $5.07 Million	CN¥1.85 Billion ≈ $270.44 Million	+0.44pp
2020-12-31	1.43%	CN¥31.63 Million ≈ $4.63 Million	CN¥2.21 Billion ≈ $322.83 Million	-1.10pp
2019-12-31	2.53%	CN¥61.00 Million ≈ $8.93 Million	CN¥2.41 Billion ≈ $352.48 Million	-6.11pp
2018-12-31	8.65%	CN¥210.58 Million ≈ $30.81 Million	CN¥2.44 Billion ≈ $356.39 Million	-11.89pp
2017-12-31	20.54%	CN¥499.72 Million ≈ $73.13 Million	CN¥2.43 Billion ≈ $356.09 Million	-6.83pp
2016-12-31	27.37%	CN¥605.06 Million ≈ $88.54 Million	CN¥2.21 Billion ≈ $323.50 Million	+2.29pp
2015-12-31	25.08%	CN¥530.00 Million ≈ $77.56 Million	CN¥2.11 Billion ≈ $309.20 Million	+21.24pp
2005-12-31	3.84%	CN¥52.70 Million ≈ $7.71 Million	CN¥1.37 Billion ≈ $200.90 Million	--

pp = percentage points

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic

Market Cap

$433.82 Million

CN¥2.96 Billion CNY

Market Cap Rank

#13187 Global

#3962 in China

Share Price

CN¥5.05

Change (1 day)

-3.63%

52-Week Range

CN¥2.61 - CN¥5.70

All Time High

CN¥24.91